Home › Funds › TCG Crossover Management, LLC › BHVN

TCG Crossover Management, LLC position in BHVN

BIOHAVEN LTD · Health Care

TCG Crossover Management, LLC reported holding 1,779,952 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$26.5M, representing 0.64% of its reported portfolio and ranking #38 among its reported holdings. TCG Crossover Management, LLC has disclosed BHVN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.78M sh
Reported value held$26.49M
Portfolio Weight0.64%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's BHVN position evolved

TCG Crossover Management, LLC first disclosed a stake in BHVN in Q4 2025 at 4,631,317 shares (US$52.3M). Across 3 filings, TCG Crossover Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,779,952 shares valued at US$26.5M — a reduction of -2,851,365 shares quarter over quarter.. Notable position changes include a 62% trim in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.63M $52.29M New
Q1 2026 4.63M $39.18M Hold
Q2 2026 1.78M $26.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BHVN and 13F data

BHVN (BIOHAVEN LTD) is a Health Care company. 29 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BHVN

All BHVN fund holders →

FAQ

How long has TCG Crossover Management, LLC held BHVN?

TCG Crossover Management, LLC has disclosed BHVN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is TCG Crossover Management, LLC's current position in BHVN?

As of Q2 2026, TCG Crossover Management, LLC holds 1.78M shares of BHVN (BIOHAVEN LTD), valued at $26.49M, representing 0.64% of its reported portfolio and ranking #38.

Has TCG Crossover Management, LLC been buying or selling BHVN?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC reduced its position in BHVN.

Which other funds hold BHVN?

Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.